Clifford Stocks

Clifford Stocks

Chief Executive Officer at OncoResponse
Seattle, Washington, United States

Clifford Stocks is the founder of OncoResponse and currently leads the company. He previously served as Executive Officer and Director at OncoResponse Inc.

OncoResponse raises $40M Series B to advance five antibody-based cancer immunotherapies into preclinical and clinical trials

OncoResponse raised $40 million in a Series B to push five antibody-based cancer immunotherapy candidates into preclinical and clinical studies, bringing total funding to nearly $70 million since its 2015 launch. The company mines antibodies from cancer patients who had exceptional responses to immunotherapy to develop treatments that modulate tumor‑microenvironment immunosuppression.

See all 4 stories, episodes and videos about Clifford Stocks.

Organizations

See all 6
  • OncoResponse Executive Officer, Director 2017–present, Chief Executive Officer 2015–present · current
  • Theraclone Sciences Chief Executive Officer 2011–2016 · past
  • Calistoga Pharmaceuticals (acquired by Gilead 2011) Chief Business Officer 2009–2011 · past

Education

  • The University of Chicago Booth School of Business MBA, Statistics; Operations; Leadership · 1986–1989
  • University of Utah B.S., Biology · 1976–1980

Online